City Drug House Exporters | Hepatitis Medicines Supplier to Washington, USA, INDIA
City Drug House Exporters supplies and exports high-quality hepatitis medicines from India to Washington, USA with trusted pharma solutions and timely global delivery.
MyHep LVIR is a fixed-dose combination antiviral medication used to treat chronic Hepatitis C virus (HCV) infection. It contains two active ingredients, Ledipasvir and Sofosbuvir, which work together at the cellular level to block HCV replication and clear the virus from the bloodstream.
Pharmacology :
Mechanism of Action :
Ledipasvir 90 mg : Inhibits NS5A, a phosphoprotein essential for viral replication and assembly.
Role in Treatment : Prevents the virus from reproducing and assembling new viral particles inside the liver cells (hepatocytes).
Sofosbuvir 400 mg : Acts as a nucleotide analog inhibitor of NS5B RNA-dependent RNA polymerase.
Role in Treatment : Incorporates into the HCV RNA chain, acting as a chain terminator and preventing further viral replication.
Pharmacokinetics:
Absorption: Both drugs are absorbed rapidly. Following oral administration, peak plasma concentrations are typically reached within 0.5 to 4 hours.
Metabolism: Sofosbuvir undergoes extensive intracellular metabolism to convert into its active pharmacological form. Ledipasvir is primarily oxidized by the liver's cytochrome P450 (CYP) enzymes.
Excretion: The primary route of excretion for Sofosbuvir is through the kidneys 80 % and feces 14 %. Ledipasvir is mainly excreted in the feces 86 %and minimally in the urine 1%.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug House Exporters supplies and exports high-quality hepatitis medicines from India to Washington, USA with trusted pharma solutions and timely global delivery.
MyHep LVIR is a fixed-dose combination antiviral medication used to treat chronic Hepatitis C virus (HCV) infection. It contains two active ingredients, Ledipasvir and Sofosbuvir, which work together at the cellular level to block HCV replication and clear the virus from the bloodstream.
Pharmacology :
Mechanism of Action :
Ledipasvir 90 mg : Inhibits NS5A, a phosphoprotein essential for viral replication and assembly.
Role in Treatment : Prevents the virus from reproducing and assembling new viral particles inside the liver cells (hepatocytes).
Sofosbuvir 400 mg : Acts as a nucleotide analog inhibitor of NS5B RNA-dependent RNA polymerase.
Role in Treatment : Incorporates into the HCV RNA chain, acting as a chain terminator and preventing further viral replication.
Pharmacokinetics:
Absorption: Both drugs are absorbed rapidly. Following oral administration, peak plasma concentrations are typically reached within 0.5 to 4 hours.
Metabolism: Sofosbuvir undergoes extensive intracellular metabolism to convert into its active pharmacological form. Ledipasvir is primarily oxidized by the liver's cytochrome P450 (CYP) enzymes.
Excretion: The primary route of excretion for Sofosbuvir is through the kidneys 80 % and feces 14 %. Ledipasvir is mainly excreted in the feces 86 %and minimally in the urine 1%.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
